Chronic granulomatous disease (CGD) is an inheritable and genetically heterogeneous disease resulting from mutations in different subcomponents of the NADPH oxidase system. Mutations in the NCF2 gene account for <5% of all cases of CGD. We analyzed the clinical and laboratory findings of CGD with mutations in the NCF2 gene from amongst our cohort of CGD patients. A homozygous mutation (c.835_836delAC, p.T279fsX294), a deletion in NCF2 gene was found in two cases. In the third case, two heterozygous mutations were detected, IVS13-2A>T on one allele and c.1099C>T (p.) on the other allele. The mother of this child was a carrier for the IVS13-2A>T mutation. All three cases had colitis, and it was the initial symptom in two patients. One of the patients also developed a lung abscess due to Nocardia cyriacigeorgica.
This is a preview of subscription content, log in to check access
Compliance with Ethical Standards
No funding sources for this manuscript.
Conflict of Interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
Pedigree of the all three families with A67° CGD- A. The affected child (shown by the arrow) born of non-consanguineous marriage with both the parents being carriers for the mutation c.835_836delAC. The elder brother could not be screened for the carrier status; B. The affected child (shown by arrow) born of non-consanguineous marriage with the mother being carrier for the mutation c.1179–2A>T; C. The affected child (shown by arrow) born of a non-consanguineous marriage with the mother being carrier for the mutation c.835_836delAC. The dihydrorhodamine testing for the elder sister was normal, however, the carrier status has not been screened till date. The mother also had a first-trimester abortion during the second pregnancy (marked as a triangle). The mother’s elder brother had died at day 1 of life. (GIF 765 bytes)
Kang EM, Marciano BE, DeRavin S, Zarember KA, Holland SM, Malech HL. Chronic granulomatous disease: overview and hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2011;127(6):1319–26. quiz 1327–8CrossRefPubMedPubMedCentralGoogle Scholar
Roos D, Kuhns DB, Maddalena A, et al. Hematologically important mutations: the autosomal recessive forms of the chronic granulomatous disease (second update). Blood Cells Mol Dis. 2010;44(4):291–9.CrossRefPubMedPubMedCentralGoogle Scholar
Badalzadeh M, Fattahi F, Fazlollahi MR, et al. Molecular analysis of four cases of chronic granulomatous disease caused by defects in NCF-2: the gene encoding the p67-phox. Iran J Allergy Asthma Immunol. 2012;11(4):340–4.PubMedGoogle Scholar
Rawat A, Singh S, Suri D, et al. Chronic granulomatous disease: two decades of experience from a tertiary care centre in North West India. J Clin Immunol. 2014;34(1):58–67.CrossRefPubMedGoogle Scholar
Noack D, Rae J, Cross AR, et al. Autosomal recessive chronic granulomatous disease caused by novel mutations in NCF-2, the gene encoding the p67-phox component of phagocyte NADPH oxidase. Hum Genet. 1999;105(5):460–7.CrossRefPubMedGoogle Scholar
Broides A, Mohammed R, Reid B, Roiffman CM, Grunebaum E. Gastrointestinal abnormalities among patients with chronic granulomatous disease. J Clin Cell Immunol. 2014;5:204.Google Scholar
Muise AM, Xu W, Guo C-H, et al. NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2. Gut. 2012;61(7):1028–35.CrossRefPubMedGoogle Scholar
de Boer M, Hilarius-Stokman PM, Hossle JP, et al. Autosomal recessive chronic granulomatous disease with absence of the 67-kD cytosolic NADPH oxidase component: identification of mutation and detection of carriers. Blood. 1994;83(2):531–6.PubMedGoogle Scholar
Jones LBKR, McGrogan P, Flood TJ, et al. Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. Clin Exp Immunol. 2008;152(2):211–8.CrossRefPubMedPubMedCentralGoogle Scholar
Winkelstein JA, Marino MC, Johnston RB, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79(3):155–69.CrossRefGoogle Scholar
Hagerman A, Rodriguez-Nava V, Boiron P, Crisinel PA, Posfay-Barbe KM. Imipenem-resistant Nocardia cyriacigeorgica infection in a child with chronic granulomatous disease. J Clin Microbiol. 2011;49(3):1185–7.CrossRefPubMedPubMedCentralGoogle Scholar
Dorman SE, Guide SV, Conville PS, et al. Nocardia infection in chronic granulomatous disease. Clin Infect Dis. 2002;35(4):390–4.CrossRefPubMedGoogle Scholar